A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain

Abroad (travel likely)RecruitingPHASE2

Conditions

Diabetic Peripheral Neuropathic Pain

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Central Research Associates, Birmingham, Alabama, United States

    Contact: Principal Investigator (David DeAtkine)
  • Synexus Clinical Research US, Inc., Phoenix, Arizona, United States

    Contact: Principal Investigator (Shawn Searle)
  • Arizona Research Center, Phoenix, Arizona, United States

    Contact: Principal Investigator (Louise Taber MD)
  • Desert Oasis Healthcare Medical Group, Palm Springs, California, United States

    Contact: Principal Investigator (Michael Jardula)
  • Artemis Institute for Clinical Research, Riverside, California, United States

    Contact: Principal Investigator (Jack Vu)
  • Artemis Institute for Clinical Research, San Diego, California, United States

    Contact: Principal Investigator (Stacey Layle)
  • CMR of Greater New Haven, Hamden, Connecticut, United States

    Contact: Principal Investigator (Joseph Soufer)
  • Bradenton Research Center, Inc., Bradenton, Florida, United States

    Contact: Principal Investigator (Eric Folkens)
  • Accel Research Sites - DeLand Clinical Research Unit, DeLand, Florida, United States

    Contact: Principal Investigator (Bruce Rankin)
  • K2 MEDICAL Research THE VILLAGES, Lady Lake, Florida, United States

    Contact: Principal Investigator (Craig Curtis)
  • K2 Medical Research ORLANDO, Maitland, Florida, United States

    Contact: Principal Investigator (Brandon Lenox)
  • Merritt Island Medical Research, LLC, Merritt Island, Florida, United States

    Contact: Principal Investigator (David Kirk)
  • Suncoast Research Group, Miami, Florida, United States

    Contact: Principal Investigator (Mark Kutner)
  • New Horizon Research Center, Miami, Florida, United States

    Contact: Principal Investigator (Lazaro Nunez)
  • Suncoast Clinical Research, Inc., New Port Richey, Florida, United States

    Contact: Principal Investigator (Cathy Barnes)
  • Renstar Medical Research, Ocala, Florida, United States

    Contact: Principal Investigator (David Oliver)
  • Precision Clinical Research, Sunrise, Florida, United States

    Contact: Principal Investigator (Richard Linn)
  • Charter Research - Lady Lake, The Villages, Florida, United States

    Contact: Principal Investigator (Stephen Miller)
  • Conquest Research, Winter Park, Florida, United States

    Contact: Principal Investigator (Anand Patel)
  • North Georgia Clinical Research, Woodstock, Georgia, United States

    Contact: Principal Investigator (Bram Wieskopf)
  • Northwestern University, Chicago, Illinois, United States

    Contact: Principal Investigator (Thomas Schnitzer)
  • DelRicht Research, New Orleans, Louisiana, United States

    Contact: Principal Investigator (Patrick Dennis)
  • Lucida Clinical Trials, New Bedford, Massachusetts, United States

    Contact: Principal Investigator (David Shih)
  • MedVadis Research Corporation, Waltham, Massachusetts, United States

    Contact: Principal Investigator (David DiBenedetto)
  • Great Lakes Research Group, Inc., Bay City, Michigan, United States

    Contact: Principal Investigator (Jeffrey Potts)
  • StudyMetrix Research, City of Saint Peters, Missouri, United States

    Contact: Principal Investigator (Timothy Smith)
  • Clinvest Research LLC, Springfield, Missouri, United States

    Contact: Principal Investigator (Ralph Duda)
  • Rochester Clinical Research, LLC, Rochester, New York, United States

    Contact: Principal Investigator (Patrick Connors)
  • Lillestol Research, Fargo, North Dakota, United States

    Contact: Principal Investigator (Michael Lillestol)
  • META Medical Research Institute, Dayton, Ohio, United States

    Contact: Principal Investigator (Priyesh Mehta)
  • DelRicht Research, Tulsa, Oklahoma, United States

    Contact: Principal Investigator (Melita Tate)
  • Altoona Center For Clinical Research, Duncansville, Pennsylvania, United States

    Contact: Principal Investigator (Alan Kivitz)
  • FutureSearch Trials of Neurology, Austin, Texas, United States

    Contact: Principal Investigator (John Hudson)
  • Re:Cognition Health - Fort Worth, Fort Worth, Texas, United States

    Contact: Principal Investigator (Claudia Perez)
  • Northwest Clinical Research Center, Bellevue, Washington, United States

    Contact: Principal Investigator (Arifulla Khan, MD)
  • Rainier Clinical Research Center, Renton, Washington, United States

    Contact: Principal Investigator (Sheryl Marks)
  • Ponce Medical School Foundation Inc., Ponce, Puerto Rico

    Contact: Principal Investigator (Elizabeth Barranco-Santana)
Study leads
  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)

    Study Director

    Eli Lilly and Company